Apellis Pharmaceuticals, Inc.

The current price of APLS is 46.77 USD — it has decreased by 1.56% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Apellis Pharmaceuticals, Inc. stocks are traded under the ticker APLS.

Apellis Pharmaceuticals, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.

APLS stock is 3.21% volatile and has beta coefficient of 0.93. Check out the list of the most volatile stocks — is Apellis Pharmaceuticals, Inc. there?

One year price forecast for Apellis Pharmaceuticals, Inc. has a max estimate of 110.00 USD and a min estimate of 57.00 USD.

APLS earnings for the last quarter are −1.17 USD per share, whereas the estimation was −0.99 USD resulting in a −17.77% surprise. The estimated earnings for the next quarter are −0.73 USD per share. See more details about Apellis Pharmaceuticals, Inc. earnings.

Apellis Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪110.40 M‬ USD despite the estimated figure of ‪99.05 M‬ USD. In the next quarter revenue is expected to reach ‪143.34 M‬ USD.

Yes, you can track Apellis Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.

APLS net income for the last quarter is ‪−88.58 M‬ USD, while the quarter before that showed ‪−140.24 M‬ USD of net income which accounts for 36.84% change. Track more Apellis Pharmaceuticals, Inc. financial stats to get the full picture.

Today Apellis Pharmaceuticals, Inc. has the market capitalization of ‪5.73 B‬, it has decreased by 3.39% over the last week.

No, APLS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, APLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Apellis Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.

APLS reached its all-time high on Jun 14, 2023 with the price of 94.75 USD, and its all-time low was 11.45 USD and was reached on Oct 24, 2018.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 706.00 employees. See our rating of the largest employees — is Apellis Pharmaceuticals, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Apellis Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Apellis Pharmaceuticals, Inc. stock shows the strong sell signal. See more of Apellis Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Apellis Pharmaceuticals, Inc. future price: according to them, APLS price has a max estimate of 110.00 USD and a min estimate of 57.00 USD. Read a more detailed Apellis Pharmaceuticals, Inc. forecast: see what analysts think of Apellis Pharmaceuticals, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Apellis Pharmaceuticals, Inc. EBITDA is ‪−515.42 M‬ USD, and current EBITDA margin is −129.96%. See more stats in Apellis Pharmaceuticals, Inc. financial statements.